Related Experiment Video

Updated: Jul 17, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

V Soriano1, J M Miró, J García-Samaniego

  • 1Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es

Journal of Viral Hepatitis
|January 24, 2004
PubMed

Insights

Updated guidelines address the management of chronic hepatitis B (HBV) and hepatitis C (HCV) in patients with human immunodeficiency virus (HIV). New treatments necessitate revised recommendations for coinfected individuals, focusing on HBV and HCV management strategies.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Chronic hepatitis B (HBV) and C (HCV) are significant causes of illness and death in people with human immunodeficiency virus (HIV).
  • Advancements in antiviral therapies for HBV and HCV necessitate updated clinical guidance for coinfected patients.

Framework:

  • A panel of Spanish experts convened to review fifteen key topics concerning HBV and HCV management in HIV-infected patients.
  • Recommendations were developed for nine HCV-related, five HBV-related, and one coinfection-specific topic.
  • The Infectious Disease Society of America (IDSA) grading system was employed to score the proposed recommendations.

Implementation:

  • The guidelines provide a comprehensive framework for managing coinfected patients.
  • Expert consensus was reached on updated treatment strategies.
  • The recommendations are designed for practical application in clinical settings.

Implications:

  • These updated guidelines offer a crucial resource for clinicians managing coinfected patients.
  • Improved management strategies can lead to better health outcomes for individuals with HIV and chronic viral hepatitis.
  • This work supports the ongoing efforts to reduce morbidity and mortality associated with HBV and HCV in the HIV-positive population.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...